Department of Medical Microbiology and Parasitology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia.
J Microbiol Immunol Infect. 2013 Jun;46(3):180-6. doi: 10.1016/j.jmii.2012.04.004. Epub 2012 Jul 2.
There is limited information about pneumococcal carriage among healthy children in Malaysia. Therefore, this study was conducted to determine the prevalence rate, serotype distribution, susceptibility pattern, and pneumococcal surface protein A (PspA) family types of Streptococcus pneumoniae isolates in the nasal carriage of children 5 years old or younger in three day care centers in Kuala Lumpur, Malaysia.
Nasal swabs were collected from 195 healthy children, age 5 years or younger, from June to December 2010. S pneumoniae was identified by phenotypic and genotypic methods. The serotyping was performed using Pneumotest kit (Statens Serum Institut, Copenhagen, Denmark) and the susceptibility pattern was determined by using the E-test method (AB Biodisk, Solna, Sweden). PspA family typing was done using polymerase chain reaction.
S pneumoniae was found in the nasal carriage of 35.4% of children (69 of 195) and penicillin resistance was found in 23.2% (16 of 69). Among the 69 isolates, multidrug-resistant S pneumoniae (MDRSP) was present in 20.3%. All 16 penicillin-resistant S pneumoniae (PRSP) isolates were resistant to erythromycin and 14 PRSPs (87.5%) were resistant to co-trimoxazole. The six most common serotypes were 6A, 23F, 19A, 6B, 19F, and 15C, which were found in 87% of all isolates. Of the 69 isolates, 24.6% belonged to PspA family 1, 71.0% to PspA family 2, and 4.3% to PspA family 3.
Twenty-eight of the isolates (40.6%) belonged to serotypes included in the pneumococcal polysaccharide vaccines (PCV) 7 and 10, whereas 48 (69.5%) were included in PCV13. The high rate of PRSP and MDRSP supports the need for continuing surveillance of pneumococcal carriage. The major PspA families were 1 and 2 (95.7%), thus making them suitable candidates for future vaccines.
马来西亚健康儿童的肺炎球菌携带情况信息有限。因此,本研究旨在确定 2010 年 6 月至 12 月期间,来自吉隆坡 3 家日托中心的 195 名 5 岁或以下健康儿童的鼻咽携带率、血清型分布、药敏模式和肺炎球菌表面蛋白 A(PspA)家族类型。
收集 195 名 5 岁或以下健康儿童的鼻咽拭子。采用表型和基因方法鉴定肺炎链球菌。采用 Pneumotest 试剂盒(丹麦哥本哈根 Statens Serum Institut)进行血清分型,采用 E 试验法(瑞典 Solna AB Biodisk)进行药敏模式测定。采用聚合酶链反应进行 PspA 家族分型。
35.4%(195 名儿童中的 69 名)的儿童携带肺炎球菌,23.2%(69 名儿童中的 16 名)对青霉素耐药。在 69 株分离株中,多重耐药肺炎链球菌(MDRSP)占 20.3%。所有 16 株青霉素耐药肺炎链球菌(PRSP)均对红霉素耐药,14 株 PRSP(87.5%)对复方磺胺甲噁唑耐药。最常见的 6 种血清型为 6A、23F、19A、6B、19F 和 15C,占所有分离株的 87%。在 69 株分离株中,24.6%属于 PspA 家族 1,71.0%属于 PspA 家族 2,4.3%属于 PspA 家族 3。
28 株(40.6%)分离株属于肺炎球菌多糖疫苗(PCV)7 型和 10 型包含的血清型,48 株(69.5%)属于 PCV13 型。高比例的 PRSP 和 MDRSP 支持对肺炎球菌携带情况进行持续监测。主要的 PspA 家族为 1 型和 2 型(95.7%),因此它们是未来疫苗的合适候选者。